These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11815367)

  • 1. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801.
    Yamada H; Nakamoto H; Suzuki Y; Ito T; Aisaka K
    Br J Pharmacol; 2002 Jan; 135(2):323-32. PubMed ID: 11815367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
    Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists.
    Sestili I; Borioni A; Mustazza C; Rodomonte A; Turchetto L; Sbraccia M; Riitano D; Del Giudice MR
    Eur J Med Chem; 2004 Dec; 39(12):1047-57. PubMed ID: 15571866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.
    Shinkai H; Ito T; Iida T; Kitao Y; Yamada H; Uchida I
    J Med Chem; 2000 Nov; 43(24):4667-77. PubMed ID: 11101358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
    Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
    Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JTC-801 alleviates mechanical allodynia in paclitaxel-induced neuropathic pain through the PI3K/Akt pathway.
    Huang J; Chen D; Yan F; Wu S; Kang S; Xing W; Zeng W; Xie J
    Eur J Pharmacol; 2020 Sep; 883():173306. PubMed ID: 32603693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice.
    Koyama T; Fukuda K
    J Anesth; 2009; 23(2):301-3. PubMed ID: 19444578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation.
    Tamai H; Sawamura S; Takeda K; Orii R; Hanaoka K
    Eur J Pharmacol; 2005 Mar; 510(3):223-8. PubMed ID: 15763246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
    Rawls SM; Schroeder JA; Ding Z; Rodriguez T; Zaveri N
    Neuropeptides; 2007 Aug; 41(4):239-47. PubMed ID: 17512052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
    Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
    Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model.
    Suyama H; Kawamoto M; Gaus S; Yuge O
    Neurosci Lett; 2003 Nov; 351(3):133-6. PubMed ID: 14623124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
    Ding Z; Raffa RB
    Br J Pharmacol; 2009 Jul; 157(5):831-43. PubMed ID: 19422392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice.
    Gunduz O; Karadag HC; Ulugol A
    Pharmacol Biochem Behav; 2011 Oct; 99(4):540-4. PubMed ID: 21664922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
    Okuda-Ashitaka E; Minami T; Matsumura S; Takeshima H; Reinscheid RK; Civelli O; Ito S
    Eur J Neurosci; 2006 Feb; 23(4):995-1004. PubMed ID: 16519664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.